CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.

Sixty-three patients with extensive-stage small-cell lung cancer were randomized to receive either cyclophosphamide, vincristine, doxorubicin and etoposide (CODE) alone or CODE plus recombinant human granulocyte colony-stimulating factor (rhG-CSF). rhG-CSF administration in support of CODE chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuoka, M., Masuda, N., Negoro, S., Matsui, K., Yana, T., Kudoh, S., Kusunoki, Y., Takada, M., Kawahara, M., Ogawara, M., Kodama, N., Kubota, K., Furuse, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063260/
https://www.ncbi.nlm.nih.gov/pubmed/9010043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063260/
https://www.ncbi.nlm.nih.gov/pubmed/9010043

Ejemplares similares